| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $26.8M | +88.4% |
| Cost of Revenue | $2.9M | +69.1% |
| R&D Expense | $295.5M | +5.6% |
| SG&A Expense | $119.9M | -1.5% |
| Operating Income | -$391.5M | -0.6% |
| Pre-tax Income | -$352.1M | -51.9% |
| Net Income | -$352.1M | -51.9% |
| EPS (Basic) | -$6.33 | -49.6% |
| EPS (Diluted) | -$6.33 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $88.2M | -36.7% |
| Inventory | $19.1M | +124.6% |
| Current Assets | $833.8M | +0.1% |
| Total Assets | $937.1M | -24.3% |
| Current Liabilities | $68.0M | +8.5% |
| Total Liabilities | $126.1M | -8.6% |
| Stockholders' Equity | $811.0M | -26.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$296.1M | +4.3% |
| Capital Expenditures | $999K | -79.5% |
| Investing Cash Flow | $239.6M | -1.5% |
| Financing Cash Flow | $5.4M | +131.2% |
| Free Cash Flow | -$297.1M | +5.5% |
| -49.6% |